EVMN

EVOMMUNE INC

EVMN·30054Y107·US·Common Stock·Healthcare - Biotechnology-Activist

EVMN (EVOMMUNE INC) is held by 71 institutional investors as of Q2 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($46.4M), JPMORGAN CHASE & CO ($23.4M), RTW INVESTMENTS, LP ($20M). Net institutional sentiment: Bullish.

71
Holders
(3 Elite)
$224.6M
Total Value
83% (66)
Consensus
55 buying - 11 selling
13F: Insider & Congress: Updated regularly
EVMN

Smart Money Verdict

View all
Loading verdict
Held by 71 funds
3 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Jul 10, 2026 · Activists Aug 14, 2026 · Congress none

ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.5.4%Aug 14, 2026
ActivistANAndera Partners3.9%Aug 14, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.5.3%Jul 16, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
3.5M$46.4M0.4%-19.76%
0
Increased
1.6M(+6.4%)$23.4M0.0%-21.09%
30
Unchanged
1.5M$20M0.2%-23.50%
0
Increased
1.4M(+3823.4%)$19.1M0.0%+5.24%
46
Increased
886,538(+31.6%)$11.8M0.0%-30.54%
35
Increased
881,895(+93.8%)$11.7M0.0%-24.76%
44
Unchanged
847,390$11.3M0.1%-40.91%
0
Increased
755,018(+53.2%)$10M0.0%-15.45%
39
Decreased
704,425(-3.0%)$9.4M0.0%-40.91%
0
New
457,015$6.1M0.0%+6.17%
38
Increased
413,553(+38.6%)$5.5M0.0%-32.42%
36
Unchanged
325,000$4.3M0.0%-19.46%
0
Decreased
306,328(-9.2%)$4.1M0.0%-40.91%
0
Increased
301,759(+21.4%)$4M0.0%-28.38%
32
Increased
293,516(+63.5%)$3.9M0.0%-26.06%
39
Increased
290,174(+1057.5%)$3.9M0.0%+0.63%
43
New
232,440$3.1M0.0%+6.17%
37
Increased
192,995(+25.1%)$2.6M0.0%-28.47%
32
Increased
178,730(+8935.9%)$2.4M0.0%+5.24%
42
Increased
133,350(+5961.4%)$1.8M0.0%+4.79%
42

Showing 1-20 of 75

1 / 4
EVMNEVMNEVOMMUNE INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used